Drugs / Bivalent Human Papilloma Virus Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05383625 | Sep 2020 → Oct 2021 | common wart | Zagazig University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent Human Papilloma Virus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05383625 ↗ |
| Modality | Vaccine | “Bivalent Human Papilloma Virus Vaccine” NCT05383625 ↗ |